SGLT2 inhibitors are already used to treat diabetes and chronic kidney disease. This study helps explain why patients taking ...

Add Yahoo as a preferred source to see more of our stories on Google. Men with both diabetes and kidney disease will develop heart health problems 28 years earlier than those without either condition, ...

SGLT2 inhibitors were linked to better kidney outcomes than GLP-1 receptor agonists in Type 2 diabetes. Learn more about the clinical impact.

New research by Stony Brook Medicine nephrology specialists that centers on targeting key cellular signaling between two types of kidney cells, and inducing a certain gene within those processes, may ...

Oral health is not just about teeth; it is deeply connected to overall health. Proper oral care help reduce risks of chronic ...

In recent years, evidence has continued to mount showing a strong relationship between diabetes, cardiovascular disease, and chronic kidney disease. This, in turn, has driven a shift to a more ...

New research reports that people with chronic kidney disease have an elevated cardiovascular disease risk eight years earlier than people without the disease. Researchers add that people with type 2 ...

Light physical activity may help lower death risk in cardiovascular-kidney-metabolic syndrome, a condition that includes heart disease, kidney disease, obesity, and type 2 diabetes.

More than half of people with advanced kidney disease develop heart problems.

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says. Men with both diabetes and kidney disease will develop heart health problems 28 years ...

A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious and common complication of the condition, has shown promising results in a ...